UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

Pacific Biosciences of California, Inc.
(Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box):

No fee required

Fee paid previously with preliminary materials

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




a2024_annualxshareholderxmr.jpg



a2024_annualxshareholderxmy.jpg



a2024_annualxshareholderxmu.jpg



a2024_annualxshareholderxmz.jpg



a2024_annualxshareholderxmw.jpg



a2024_annualxshareholderxmv.jpg



a2024_annualxshareholderxmx.jpg



a2024_annualxshareholderxmt.jpg



a2024_annualxshareholderxmn.jpg



a2024_annualxshareholderxms.jpg



a2024_annualxshareholderxmo.jpg



a2024defa14a-additionalmata.jpg



a2024defa14a-additionalmat.jpg







a2024_annualxshareholderxmp.jpg



a2024_annualxshareholderxmq.jpg






Pacific Biosciences of C... (NASDAQ:PACB)
過去 株価チャート
から 5 2024 まで 6 2024 Pacific Biosciences of C...のチャートをもっと見るにはこちらをクリック
Pacific Biosciences of C... (NASDAQ:PACB)
過去 株価チャート
から 6 2023 まで 6 2024 Pacific Biosciences of C...のチャートをもっと見るにはこちらをクリック